Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Jul 9;8(11):4976–4985. doi: 10.1002/cam4.2371

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Outcomes in CML patients according to KIR genotype. A, First DMR, which did not differ significantly according to KIR2DL5B status, B, TFR, which did not differ significantly according to KIR2DL5B status, C, Second DMR, which differed significantly according to KIR2DL5B status. D, TFR, which did not differ significantly according to haplotype assignment; CML, Chronic Myeloid Leukemia; DMR, Deep molecular response; KIR, Killer Immunoglobulin‐like Receptors; TFR, Treatment‐free remission.